Shenzhen Chipscreen Biosciences Co Net debt/EBITDA
Was ist das Net debt/EBITDA von Shenzhen Chipscreen Biosciences Co?
Net debt/EBITDA von Shenzhen Chipscreen Biosciences Co., Ltd. ist 5,565.30
Was ist die Definition von Net debt/EBITDA?
The net debt to earnings before interest, taxes, depreciation, and amortization (Net debt/EBITDA) ratio measures financial leverage and the company’s ability to pay off its debt. It shows how long it would take the company to pay off all its debt with operations at the current level.
The net debt to EBITDA ratio is calculated as Net debt divided by EBITDA. It is similar to the debt to EBITDA ratio, but cash and cash equivalents are subtracted in net debt.
Net debt = short-term debt + long-term debt - cash and cash equivalents
EBITDA = net income + interest expense + taxes + depreciation + amortization
Lower debt debt to EBITDA ratio indicates the company is not heavily indebted and should be able to repay its obligations. Alternatively, higher ratio indicated the company is excessively indebted. The ratio varies between industries as different industries have different capital requirements. Usually, the ratio should be compared to a benchmark or an industry average to determine the company’s credit risk. Generally, a net debt to EBITDA ratio above 4 or 5 is considered high.
Net debt/EBITDA von Unternehmen in Health Care Sektor auf SSE im Vergleich zu Shenzhen Chipscreen Biosciences Co
Was macht Shenzhen Chipscreen Biosciences Co?
Shenzhen Chipscreen Biosciences Co., Ltd. engages in the research, development, and sale of original small molecule drugs. The company develops precursor compounds and original new drug product lines that are in various research phase of the specific global intellectual property protection in three areas, such as cancer, metabolic diseases, and autoimmune diseases. Shenzhen Chipscreen Biosciences Co., Ltd. was founded in 2001 and is based in Shenzhen, China.
Unternehmen mit net debt/ebitda ähnlich Shenzhen Chipscreen Biosciences Co
- Mechel PJSC hat Net debt/EBITDA von 3,412.93
- MAN SE hat Net debt/EBITDA von 3,439.00
- Cresud hat Net debt/EBITDA von 3,527.59
- Dealnet Capital hat Net debt/EBITDA von 3,642.37
- EPI () hat Net debt/EBITDA von 4,336.87
- KT hat Net debt/EBITDA von 4,758.28
- Shenzhen Chipscreen Biosciences Co hat Net debt/EBITDA von 5,565.30
- Aemetis Inc hat Net debt/EBITDA von 6,195.62
- TTL Beteiligungs- und Grundbesitz-AG hat Net debt/EBITDA von 6,283.54
- Prospect Resources hat Net debt/EBITDA von 6,818.24
- Enel Chile S.A hat Net debt/EBITDA von 7,379.66
- Boeing Co hat Net debt/EBITDA von 7,664.71
- SK Telecom Co Ltd hat Net debt/EBITDA von 7,844.35